Clinical Trials Directory

Trials / Sponsors / Pulmotect, Inc.

Pulmotect, Inc.

Industry · 7 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingPUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Sync
Hematologic Malignancies, Hematopoietic Stem Cell Transplant (HSCT)
Phase 22025-06-27
WithdrawnA Multiple Ascending Dose Study of PUL-042 in Stem Cell Transplant Recipients
Hematologic Diseases, Stem Cell Transplants
Phase 12024-12-01
CompletedThe Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 In
COVID-19
Phase 22020-06-16
CompletedThe Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2
COVID-19
Phase 22020-06-09
CompletedThe Effect of Inhaled PUL-042 on Rhinovirus-induced Symptoms in Smokers With GOLD Stage 0 COPD
COPD
Phase 22019-01-21
CompletedEffect of Pre-Treatment With Cromolyn or Albuterol on Response to PUL-042 Inhalation Solution (PUL-042)
Healthy
Phase 12015-07-01
CompletedSafety and Tolerability of Single Ascending Doses of PUL-042 Inhalation Solution in Healthy Subjects
Healthy
Phase 12014-02-01